JonasVan den Bossche

Partner

Bruxelles + 32.2.645.14.12

Contact

Partager

Jonas Van den Bossche has 15 years of experience in complex domestic and cross-border M&A deals, joint ventures, private equity, and real estate transactions. He also advises clients on general civil, commercial, corporate governance, corporate law, and restructuring issues. Jonas has been with Jones Day since 2008 and also spent 18 months in the Firm's London Office, where he advised on cross-border M&A, capital markets, and private equity transactions.

Recent representative transactions include Suez' €1.1 billion divestiture of its recycling and recovery operations in four European countries to PreZero, Biobest's €98.5 million capital increase by Sofina, Pandox's acquisition of the NH Louise hotel, and Hansteen's sale of its entire Belgian real estate portfolio.

Other major companies Jonas has advised include Arsenal Capital, Astellas, Barco, Bridgestone, Diebold, Euroclear, Global City Holdings N.V., Heidrick & Struggles, Hexagon, International Automotive Components Group, MasterCard, Mitsui Chemicals, Nitto, Pioneer, Procter & Gamble, Solvay, Toyota Motor Corporation, Wabtec Corporation, and Van Hool.

Expérience

  • SmartSD enters into strategic partnership with CobepaJones Day advised SmartSD and its longstanding stakeholders Smile Invest, co-founders and management on a strategic partnership with new majority shareholder Cobepa, a leading European private equity company.
  • GfK sells European Consumer Panel (GfK CP) business to YouGovJones Day advised GfK SE in the €315 million sale of its European Consumer Panel business (GfK CP) to YouGov PLC, a leading international online research data and analytics technology group headquartered in the United Kingdom and listed on the London Stock Exchange (LSE: YOU).
  • Biobest acquires BiotropJones Day represented Biobest Group NV, a Belgian developer of biological crop-protection products in its €500 million capital and debt raise for the acquisition of Biotrop Participacoes SA, a provider of biological and natural farming solutions in Brazil, for an enterprise value of about €532 million.
  • Norwest Equity Partners acquires United Sports BrandsJones Day represented Norwest Equity Partners in the acquisition and financing of United Sports Brands, a global leader in sports performance and protective products, including the Shock Doctor, McDavid, Cutters, Nathan, PEARL iZUMi, and Glukos brands.
  • Cortec Group sells Chauvet & Sons to Court Square Capital PartnersJones Day advised Cortec Group in the sale of its Chauvet & Sons platform to Court Square Capital Partners.
  • Diebold Nixdorf obtains $1.25 billion senior secured exit credit facilityJones Day represented Diebold Nixdorf, Incorporated, a multinational financial and retail technology company that specializes in the sale, manufacture, installation, and service of self-service transaction systems (such as ATMs and currency processing systems), point-of-sale terminals, physical security products, and software and related services for global financial, retail, and commercial markets, in connection with a new $1.25 billion senior secured term loan facility as part of it’s emergence from chapter 11 bankruptcy and other domestic and foreign court-supervised restructuring proceedings.
  • Diebold Nixdorf successfully restructures over $2.7 billion in funded debt and completes the first-ever dual proceeding under the U.S. bankruptcy code and Dutch restructuring law in 71 daysIn the first-ever cross border restructuring involving dual main proceedings under chapter 11 of the U.S. Bankruptcy Code and a scheme of arrangement (the "Dutch Scheme") under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord ("WHOA")), and the first-ever chapter 15 recognition of Dutch Scheme proceedings and a sanctioned WHOA reorganization plan (the "WHOA Plan"), Jones Day represented Diebold Nixdorf, Incorporated ("Diebold") and certain of its U.S. and Canadian subsidiaries (the "Debtors") in connection with (i) the prepackaged chapter 11 cases of In re Diebold Holding Company, LLC, et al., (Case No. 23-90602-DRJ) commenced on June 1, 2023, in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"); (ii) the Dutch Scheme, commenced on June 1, 2023 by Diebold Nixdorf Dutch Holding B.V. (the "Dutch Issuer") in the District Court of Amsterdam (the "Dutch Court"), and (iii) the chapter 15 proceedings before the Bankruptcy Court commenced by the foreign representative of the Dutch Issuer, wherein the Bankruptcy Court recognized the Dutch Scheme proceeding as a foreign main proceeding and recognized and extended comity to the WHOA Plan that was sanctioned by the Dutch Court.
  • Diebold Nixdorf obtains $1.25 billion senior secured superpriority DIP credit facilityJones Day is representing Diebold Nixdorf, Incorporated (the “Company”), a multinational financial and retail technology company that specializes in the sale, manufacture, installation, and service of self-service transaction systems (such as ATMs and currency processing systems), point-of-sale terminals, physical security products, and software and related services for global financial, retail, and commercial markets, and certain of its domestic and foreign subsidiaries (collectively, the “Debtors”) in (i) a pre-packaged chapter 11 proceeding in front of the U.S. Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”), (ii) a scheme of arrangement by Diebold Nixdorf Dutch Holding B.V. (the “Dutch Issuer”) and the related voluntary proceeding in front of the District Court of Amsterdam under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord), and (iii) an anticipated proceeding commenced by the Dutch Issuer under chapter 15 in the Bankruptcy Court, seeking recognition of such scheme of arrangement.
  • Biobest receives capital increase from Sofina and some private investorsJones Day advised Biobest Group NV in its capital increase in an amount of €98.5 million with cancellation of preferential subscription rights, subscribed by Sofina SA and by other private investors.
  • Sumitomo Bakelite Europe subsidiary acquires industrial land in Ghent, BelgiumJones Day advised Sumitomo Bakelite Europe NV in the acquisition by subsidiary Vyncolit NV of industrial land at the Vynckier site (Ghent, Belgium) from Gegrond BV.
  • Pandox acquires NH Brussels LouiseJones Day advised Pandox AB in the €35 million acquisition of NH Brussels Louise, a hotel in central Brussels, Belgium.
  • iSTAR Medical enters into strategic alliance with AbbVieJones Day advised iSTAR Medical SA in its strategic alliance with AbbVie (NYSE: ABBV).
  • Consortium BelGaN Group BV acquires ON Semiconductor Belgium BVJones Day advised the consortium BelGaN Group BV with the acquisition of ON Semiconductor Belgium BV, a subsidiary of Semiconductor Components Industries, LLC, which designs and manufactures semiconductors components.
  • PTTGC acquires allnex from AdventJones Day advised PTT Global Chemical Public Company Limited in the €4 billion acquisition of allnex Holding GmbH from Advent International.
  • Aurelius sells remaining Office Depot Europe business to strategic buyer RAJA GroupJones Day advised AURELIUS Equity Opportunities in the sale of Office Depot Europe, which includes the remaining Viking and Office Depot Europe activities to strategic buyer RAJA Group.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health in connection with the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • EMERAM Capital Partners sells portfolio company MEONA to Trill ImpactJones Day represented EMERAM Capital Partners GmbH, one of the leading investment companies for medium-sized companies in the German-speaking region, in the sale of its portfolio company MEONA, an innovation leader for clinical software, to the private equity firm, Trill Impact.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • SUEZ sells its SUEZ Recycling & Recovery operations to PreZeroJones Day advised the French listed company SUEZ SA in its largest sale of SUEZ Recycling & Recovery operations - excluding plastic recycling and hazardous waste treatment activities - in four continental Europe countries: the Netherlands, Luxembourg, Germany, and Poland to PreZero, the environmental division of Schwarz Group.
  • EIC acquires assets of CG Power Systems BelgiumJones Day advised Electrical Industries Company (EIC) in the acquisition of the production activities from the assets of the bankrupt estate of CG Power Systems Belgium.
    •

    December 2020 Commentary

    European Government Support Schemes: Current State of Play

    June 2020 White Paper

    Financial Government Support Measures Related to COVID-19 for European Corporates

    March 2019 Commentary

    Belgium Enacts Historic Corporate Law Reform

    Autres publications

    • December 2020
      Shareholders’ Agreements following the introduction of the New Belgian Companies and Associations Code (DAOR 2020/4)

    Interventions

    • June 14, 2022
      Lecture for the Flemish Pleading Association (Vlaams Pleitgenootschap) of the Brussels bar on "An Overview of the Impact of the New Company Code on Existing and New Shareholders' Agreements"
    • January 15, 2019
      ELSA Maastricht lecture on "Introduction to Mergers & Acquisitions in Practice - A Perspective of Law and Business"

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.